Imaging Workflow and Patient Preparation GLP-1 medications also affect how imaging exams are performed, not just what they show
Depending on the patient, support may include: Reviewing when nausea started Checking whether symptoms relate to dose changes Reviewing meal size, fat intake, hydration, and protein Adjusting nutrition strategies for nausea or heartburn Monitoring weight-loss progress and side effects Discussing whether medication timing, dose plan, or follow-up should be reviewed Helping protect lean mass with protein and activity guidance Escalating care if red-flag symptoms are present Relevant MTC services may include GLP-1 weight-loss injections, nutritional counseling and coaching, medical weight loss, metabolic testing, 3D body scanning, and weight loss maintenance support
Australia GLP-1 Receptor Agonist Market Growth Factors Increased adoption of GLP-1 receptor agonists: The safety and efficacy of GLP-1 receptor agonists for type 2 diabetes and obesity management is increasing the demand and adoption in the Australian population
Comparative effectiveness of DPP-4 inhibitors versus sulfonylurea for the treatment of type 2 diabetes in routine clinical practice: A retrospective multicenter real-world study
Effects of GLP-1 receptor agonists on incident gynecologic cancer outcomes in endometriosis patients compared to metformin: a real-world cohort
In these cases L-carnitine is a conditionally essential nutrient that must be obtained through supplementation and/or from high carnitine whole foods including meat and seafood